EPO and proliferative diabetic retinopathy: Indeed, a single nucleotide polymorphism in the human EPO gene promoter is associated with increased EPO in the vitreous and severe microvascular complications in diabetes, proliferative diabetic retinopathy, and end-stage renal disease [179].